IP Infustion
News/Events About Products Solutions Services Partners Support
 Home » News/Events » Press Release
 
 

 
 

Press Release

IP Infusion Expands Global Operations With An Office In Germany

February 15, 2005, San Jose, California – IP Infusion Inc., the leading provider of intelligent network software for enhanced IP services platforms, today announced that it has opened a regional sales office in Munich, Germany, led by Mr. Thomas Krause. The decision to add a regional office in Germany was prompted by growing business opportunities for the company’s flagship ZebOS® integrated advanced routing and switching software suites.

The addition of the German sales office is part of IP Infusion’s corporate strategy to increase its focus on the Central European market, which includes Germany, Austria, and Switzerland. This regional office will report to the IP Infusion EMEA (Europe, Middle East and Africa) headquarters located in Paris, France and led by Mr. Eric Zardi, director of EMEA sales.

“We believe that the European market has tremendous opportunity for growth and that IP Infusion is the ideal partner for delivering next generation communication equipment,” said Mr. Len Eisenstein, Vice President of Worldwide Sales of IP Infusion. “Having a second local presence in Europe is crucial to developing a deeper understanding of the unique needs of our customers and providers in central Europe. The German office makes it possible for us to work collaboratively and effectively with our local customers to enable the success of their product development and entrance into the market."

For sales inquiries for Germany, Austria, and Switzerland, Mr. Thomas Krause can be reached at IP Infusion’s office in Munich, Germany. Phone: +49.89.79.35.55.19Fax: +49.89.79.35.55.18, Email: thomas.krause@ipinfusion.com.

About ZebOS Advanced Routing and Switching Software Suites
The ZebOS Advanced Routing Suite is a sophisticated, robust, and standards-based Layer 2 and Layer 3 carrier-class routing and switching software solution. It is currently in use at many sites worldwide and is one of the most popular routing and switching protocol packages available on the market today. ZebOS provides a broad suite of IPv4, IPv6, Multicast and MPLS switching and traffic engineering offerings that include full-featured, extensively tested, and mature protocols. In particular, its advanced IPv6 and MPLS solutions have been addressing the needs of markets worldwide for some time and will play a key role in enabling equipment vendors to deliver differentiated solutions.

About IP Infusion
IP Infusion Inc., the leading provider of intelligent network software for enhanced IP services platforms, delivers routing, switching, multicast, and QoS technology, enabling equipment vendors and end-users to rapidly develop and deploy solutions for the access, enterprise, and provider edge markets. IP Infusion has extended its software to allow vendors to address a wide variety of value-added IP services markets. IP Infusion continues to develop network software solutions that provide equipment vendors with building blocks to rapidly create modular and scalable high-performance solutions around best-of-breed network hardware and software products from vendors such as Intel, Broadcom, Wind River, and MontaVista. Its software is deployed worldwide in network equipment in the enterprise, telecommunications, and service provider spaces throughout Asia, North America, and Europe. IP Infusion has both gained design wins in the enterprise and security solutions markets and taken a leadership position in the growing IPv6, virtualization, and high-availability network equipment market. For more information about IP Infusion, please visit www.ipinfusion.com.

Thomas Krause
IP Infusion Inc.
Office: +49.89.79.35.55.19
Fax: +49.89.79.35.55.18
thomas.krause@ipinfusion.com

###

ZebOS and IP Infusion are registered trademarks and the ipinfusion logo is a trademark of IP Infusion Inc. All other names mentioned are trademarks, registered trademarks, or service marks of their respective companies.